GSK
Get informed when a big investor buys or sells
+ FollowJuly 28, 2026 - AI Summary
Undervalued by 112.2% based on the discounted cash flow analysis.
| Market cap | $105.00 Billion |
|---|---|
| Enterprise Value | $120.05 Billion |
| Dividend Yield | $1.80 (3.54%) |
| Earnings per Share | $2.82 |
| Beta | 0.3 |
| Outstanding Shares | 2,007,000,000 |
| P/E Ratio | 15.99 |
|---|---|
| PEG | -22.94 |
| Price to Sales | 0.35 |
| Price to Book Ratio | 6.39 |
| Enterprise Value to Revenue | 0.4 |
| Enterprise Value to EBIT | 6.47 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 1.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1903▲ 63.81% |
|---|---|
| Total Calls | 2,006,200▼ 38.73% |
| Total Puts | 2,387,900▲ 32.09% |
Holdings and activity of institutional investors.
| Ownership % | 17.24%▼ 1.38% |
|---|---|
| Total Invested | $18.16B▼ 12.07% |
| Investors Holding | 1,054▼ 7.00% |
No data